Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaillie Geu Regulatory News (BGEU)

Share Price Information for Baillie Geu (BGEU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 99.00
Bid: 99.10
Ask: 99.50
Change: 1.20 (1.23%)
Spread: 0.40 (0.404%)
Open: 97.80
High: 99.50
Low: 97.80
Prev. Close: 97.80
BGEU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Baillie Gifford European Growth Half-year Report

17 May 2022 07:00

RNS Number : 6784L
Baillie Gifford European Growth Tst
17 May 2022
 

RNS Announcement

 

Baillie Gifford European Growth Trust plc

 

Legal Entity Identifier: 213800QNN9EHZ4SC1R12

 

Regulated Information Classification: Half Yearly Financial Report

 

Results for the six months to 31 March 2022

 

Over the six month period, the Company's net asset value per share (NAV) total return was -24.7% compared with a total return of -5.2% for the FTSE Europe ex UK index, in sterling terms. The Company's share price total return for the same period was -28.8%.

 

· Over the 28 months to 31 March 2022, being the period under the management of Baillie Gifford, the Company's NAV total return was 27.0% compared with a total return of 15.8% for the FTSE Europe ex UK index, in sterling terms. The share price total return for the same period was 29.7%.

· During the six month period four new positions were taken (tonies, McMakler, Topicus.com and Embracer) and seven existing positions were added to (Aker Horizons, VNV Global, Allegro, Prosus, Just Eat Takeaway, Wizz Air and Delivery Hero).

· At the AGM shareholders approved an increase in the maximum amount that may be invested in unlisted investments, from 10% to 20% of total assets.

· Invested gearing stood at 11.1% at the end of the period.

 

Past performance is not a guide to future performance

 

Total return information is sourced from Refinitiv, Baillie Gifford and relevant underlying index providers. See disclaimer at end of this announcement.

 

Baillie Gifford European Growth Trust aims to achieve capital growth over the long-term from a diversified portfolio of European securities. At 31 March 2022 the Company had total assets of £461m.

 

Baillie Gifford European Growth Trust is managed by Baillie Gifford, an Edinburgh-based fund management group with approximately £239 billion under management and advice as at 16 May 2022.

 

 

Baillie Gifford European Growth Trust is a listed UK company. The value of its shares and any income from them can fall as well as rise and investors may not get back the amount invested. The Company is listed on the London Stock Exchange and is not authorised or regulated by the Financial Conduct Authority. You can find up-to-date performance information about Baillie Gifford European Growth Trust at bgeuropeangrowth.com. Past performance is not a guide to future performance.

 

17 May 2022

 

 

For further information please contact:

Naomi Cherry, Baillie Gifford & Co

Tel: 0131 474 5548

 

Jonathan Atkins, Four Communications

Tel: 020 3103 9553 or 07872 495 396

 

 

Neither the contents of the Managers' website nor the contents of any website accessible from hyperlinks on the Managers' website (or any other website) is incorporated into, or forms part of, this announcement.

 

The following is the unaudited Interim Financial Report for the six months to 31 March 2022 which was approved by the Board on 16 May 2022.

 

 

Interim Management Report

 

We live in uncertain and often disheartening times. Crisis follows crisis. 'Out of the frying pan and into the fire' would be an apt metaphor if the nightmare of the aforementioned pan had ended, but the dislocations of the pandemic still ripple through our lives only now aided and abetted by Russia's invasion of Ukraine. Economic uncertainty abounds with inflation rife, rising interest rates and a growing probability of recession, but geopolitical uncertainty is equally prevalent. Germany is re-arming; Finland and Sweden are openly considering NATO membership; and Switzerland has abandoned its neutrality. None of us expected such tectonic shifts six months ago. More recently, the French Presidential elections added fuel to the fire, with rampant speculation about a possible 'Frexit' had Marine Le Pen won. President Macron's victory may have calmed fears for now, but resolution is a luxury in this environment. Seldom have there been so many reasons to fear Europe. Add to all this the collapse of the Company's share price since September and you'd be forgiven for wondering how we manage to get up in the morning.

The principal reason we do - and our overriding motivation - is because we see a different version of the world, one expressed by the portfolio we have constructed. It is a portfolio of companies driving and benefiting from inexorable, momentous changes that promise to rewrite industries, habits and lives. Upstaged by fever pitch noise, it is altogether too easy to forget the underlying revolution in biotechnology driven by advances in gene sequencing and other novel tools, or the paradigm shifts underway in our relationship with food, or global decarbonisation, or the digitisation of retail and so on. In a decade's time we suspect that it is the big intrinsic shifts to which our portfolio companies are exposed that will be proven to matter far more than the next rate hike or another few months of high inflation.

Our preoccupations therefore reflect this. Most of our time is spent analysing companies through an optimistic lens, not sifting through myopic headlines. We focus on the long term and devote ourselves to considering the potential upside should our companies thrive. As Hendrik Bessembinder demonstrates in his 2017 paper, 'Do Stocks Outperform Treasury Bills?', long-term returns in stock markets tend to be driven by a handful of extraordinary outliers. In fact, from 1926 to 2016, just 4% of US stocks accounted for the entire period's net wealth creation, or US$35tn. A further paper in 2019 discovered that this was even more extreme outside the US. What is also striking is that, if one looks at the many of these long-term winners, they have at times been short-term losers. Amazon generated US$865bn of shareholder wealth between June 1997 and December 2019, but in September 2001 it experienced a 93% fall, and from September 2007 to November 2008 it experienced a 56% fall.

Sticking with these companies can therefore be hard when the market tells you that you're wrong, sometimes for long periods of time. A long-term focus is crucial. What's clear from Bessembinder's work is that extreme winners only become so over many years, not a handful of quarters. His research also shows that the average share price drawdown in the same decade as extraordinary success for the extreme winners is 32.5%, and that these drawdowns last, on average, for ten months. This is a lifetime in today's myopic market. Optimism, open-mindedness, and an ability to cut through short-term noise are vital if one is to exploit the long-term returns outliers can generate. We're therefore willing to pay the short-term price of seeming foolish.

Crucially, our optimism also stems from what we're seeing in company fundamentals. For calendar year 2022, the expected revenue growth rate for our portfolio is 25% and for the next three years it is 19%pa. Compare this to the 10%pa anticipated three- year forward revenue growth rate for the portfolio at the end of calendar 2019. Balance sheets are also in good shape, with the average net debt/EBITDA ratio for the portfolio standing at 0.6x compared to 1.8x for the benchmark. Among our top 10 performance detractors for the period, six were profitable last year, another three were only unprofitable because they prioritised investment and the other (Wizz Air) was cyclically depressed thanks to the pandemic. What strikes us generally is that fundamentals appear to be on track, yet valuations have collapsed. We won't get everything right, but this gives us confidence in the prospects for the portfolio.

 

Performance

Over the six months to 31 March 2022, the Company's net asset value per share, total return, was -24.7% while the FTSE Europe ex-UK index returned -5.2% over the same period in sterling terms. The Company's share price returned -28.8% to 108p representing a discount of 6.7% to the net asset value per share. This compares to a discount of 1.3% at the beginning of the period. The company bought back an aggregate 5.7m shares during the period. From the period end to 13 May 2022, the Company's net asset value per share has decreased by 14.2% and the share price by 19.1%, compared with a fall in the FTSE Europe ex UK index of 5.3%. 

Such challenging performance is never easy to endure. It's especially difficult looking through our performance attribution statistics and seeing so few strong positive contributors. Dealing with periods of tough performance is, however, part of the job. From time to time even the very best managers will underperform. We have spoken in the past about the largely random nature of short-term share price movements, which tend to reflect sentiment far more than fundamentals. While this brings us comfort it risks sounding pontifical. What matters more is that the underlying fundamentals of most companies in the portfolio are strong and good progress is being made against our investment hypotheses. This is not to paint the picture of a perfect world, but on balance there's much to champion that simply isn't being captured by share prices. If we were seeing widespread operational weakness, we'd be feeling significantly less enthusiastic.

This progress is especially true for some of the most heavily sold-off companies in the portfolio. Over the period the average total return for our top ten detractors was roughly -50%, yet among these names one can find some of the highest-growth companies in the portfolio, most of which are profitable or unprofitable by choice. Such a drastic compression of multiples in so short a time has therefore taken us by surprise. Delivery Hero, for example, is aiming to grow revenues around 60-75% this year, despite having doubled revenues in 2020 and more than doubled revenues in 2021. Its longer-term ambition is to grow its gross transactional value to €200-350bn from the €44-45bn guided for this year, yet today's multiples have compressed to the extent that such an outcome simply isn't contemplated in today's share price. Similar arguments could be made for other high-growth companies in the portfolio and we are seeking to take advantage of the resulting opportunities.

It would be remiss to say nothing of the conflict in Ukraine. The impact of this dreadful war on the portfolio is difficult to estimate and, while some knock-on effects are already evident, others will take time to manifest. Wizz Air, which also appears in our top ten detractors for the period, has seen four of its planes trapped in Ukraine, and in the early part of the conflict some crews too. Management viewed Ukraine as a key market for future growth, and planned a significant expansion there. This is clearly now on hold. Elsewhere, holding company Prosus has also felt the impact of the war via its exposure to Russia where it owns local classifieds business Avito and a stake in VK Group. Prosus is in the process of decoupling Avito and will write down its stake in VK. Thankfully these businesses only accounted for 5% of Prosus' accounting value. Many other businesses touch the affected region in different ways, but at this point we have little to add other than to simply note that the direct revenue exposure of the overall portfolio is less than 2%. We continue to monitor our companies closely.

In summary, while performance in the near-term has been tough, we remain optimistic about our companies and their ability to deliver over the long-term.

Transactions

Underlying turnover for the period was slightly higher than usual. This is largely a function of market volatility and our attempts to exploit the resulting opportunities among existing holdings. We continue to believe in the value of owning special companies for long periods of time. There aren't many companies that reach our initial bar and so we added only four new holdings over the period. Two of these - Topicus.com and Embracer - are consolidators, or companies that grow primarily through acquisition. Topicus was spun out of Constellation Software in January 2021 and acquires vertical market software companies in bolt-on-style deals, while Embracer acquires gaming companies in a mixture of large and small transactions. We think both companies have long runways for capital allocation and unique cultures. As noted in the previous annual report, we agreed to take a holding in SPAC 468 I, which merged with German toy company Boxine. This was done via a private placement or PIPE (private investment in public equity). The merger is now complete and the resulting entity, renamed tonies to reflect its flagship children's product, has formally become a holding. Reflecting our increasing enthusiasm for opportunities in the European unlisted space and shareholders' approval at the recent AGM of an increase in the amount that we can invest therein, we added our fourth unlisted investment in the form of German digital real estate agent McMakler.

We also made several additions to existing holdings during the period. We participated in a private placement by green investment company Aker Horizons in November as a means of increasing our initial small holding size. In a similar vein, with growing enthusiasm for VNV Global, we decided to increase the holding size. New purchases Topicus and Embracer also received additional capital over the course of the period as we sought to grow our positions in both companies. Several existing holdings saw significant share price declines into the end of the 2021 calendar year and the first quarter of 2022, and we made additions to names where the sell-off felt extreme and our conviction consequently deepened. Allegro, Prosus, Just Eat Takeaway, Wizz Air and Delivery Hero all received more capital as we felt our view had become increasingly differentiated to the market.

These ideas required funding, which we secured through complete sales of five stocks and partial sales of others. We parted ways with L'Oréal and Investor, longstanding holdings in our European funds, not out of concerns over business quality but rather over doubts about likely future growth rates and the starting valuation multiples. Elsewhere, we sold Bechtle, Morphosys and Pernod Ricard for similar reasons. We also made reductions to AddLife, DSV, IMCD, Kuehne + Nagel, ASML, Beijer and NIBE as valuations felt increasingly stretched against our expectations, as has occasionally been the case over the past two years in particular.

Outlook

As usual, we have no views to share on inflation, interest rates and the plethora of other macroeconomic factors into which we have no insight and over which we have no control. We can, however, control the composition of the portfolio and believe we have assembled a collection of companies with significant opportunities to grow meaningfully, deepening competitive advantage, high levels of shareholder alignment and attractive valuations. We cannot predict whether our recent underperformance will persist, or for how long, but we can assure shareholders that we remain devoted to building a portfolio capable of generating the long-term returns they rightly demand. Importantly, we feel well-placed to exploit an increasingly rich European universe at a time when sentiment towards European growth has seldom seemed so gloomy.

 

 

Baillie Gifford & Co

16 May 2022

 

The principal risks and uncertainties facing the Company are set out at the back of this announcement.

 

Past performance is not a guide to future performance.

For a definition of terms see Glossary of Terms and Alternative Performance Measures, see below.

Total return information is sourced from Refinitiv, Baillie Gifford and relevant underlying index providers. See disclaimer at the end of this announcement.

List of Investments as at 31 March 2022 (unaudited)

 

 

 

Name

 

 

Business

 

 

Country

 

Value

£'000

% of total assets

Prosus

Investment company

Netherlands

22,896

5.0

Northvolt U

Battery developer and manufacturer

Sweden

20,619

4.5

Adyen

Global payment company

Netherlands

20,037

4.3

Ryanair

Low-cost European airline

Ireland

18,419

4.0

Atlas Copco

Industrial compressors manufacturer

Sweden

17,331

3.8

IMCD

Speciality chemical distributor

Netherlands

17,034

3.7

Avanza Bank

Online savings and investment platform

Sweden

15,097

3.3

Zalando

Online fashion retailer

Germany

13,808

3.0

ASML

Semiconductor equipment manufacturer

Netherlands

13,017

2.8

Allegro.eu

E-commerce marketplace

Poland

12,920

2.8

Kingspan

Provides high performance insulation

and building envelope technologies Ireland

12,639

2.7

Richemont

Luxury goods company

Switzerland

11,592

2.5

adidas

Global sportswear brand

Germany

11,410

2.5

Kering

Luxury brand conglomerate

France

11,365

2.5

Spotify

Online music streaming service

Sweden

10,774

2.3

Reply

IT consultancy

Italy

10,767

2.3

Dassault Systèmes

Software company

France

10,041

2.2

NIBE

International heating technology company

Sweden

9,840

2.1

Kinnevik

Investment company

Sweden

9,756

2.1

Takeaway.com

Online food delivery service

Netherlands

9,695

2.1

Mettler-Toledo

Manufacturer of precision weighing

equipment

Switzerland

9,526

2.1

Wizz Air

Low-cost airline

Hungary

9,273

2.0

Hexpol

Manufacturer of rubber and plastic

components

Sweden

8,993

2.0

Schibsted

Media and online classifieds company

Norway

8,804

1.9

Nexans

Manufacturer of low, medium and high

voltage cables

France

8,606

1.9

Sartorius Stedim Biotech

Pharmaceutical and laboratory equipment

provider

France

8,570

1.9

Adevinta

Online classifieds

Norway

8,268

1.8

Beijer

Refrigeration and air conditioning

Sweden

7,991

1.7

Delivery Hero

Online food delivery service

Germany

7,134

1.6

Topicus.com

Vertical market software provider

Netherlands

7,087

1.5

AddLife

Distributor of medical and laboratory

equipment Sweden

7,030

1.5

HelloFresh

Grocery retailer

Germany

6,772

1.5

Kuehne + Nagel

Freight forwarding and logistics company

Switzerland

6,152

1.3

sennder Technologies U

Digital freight forwarder

Germany

6,133

1.3

Rational

Cooking equipment manufacturer

Germany

5,965

1.3

McMakler U

Digital real estate agent

Germany

5,914

1.3

Embracer

Game developer

Sweden

5,849

1.3

FinecoBank

Savings and investment platform

Italy

5,648

1.2

Aker Horizons

Renewable energy and green technology

 platform

 

Norway

 

5,609

 

1.2

DSV

Freight forwarding and logistics company

Denmark

5,320

1.2

AUTO1

Digital automotive platform

Germany

5,250

1.1

Epiroc

Supplier to mining and construction industries

 

Sweden

 

5,171

 

1.1

Ubisoft Entertainment

Video games publisher

France

4,647

1.0

VNV Global

Investment company

Sweden

3,904

0.9

tonies

Manufacturer of digital children's toys

Germany

3,668

0.8

Flixmobility U

European transport company

Germany

3,573

0.8

Hemnet

Online property platform

Sweden

3,500

0.8

Cellectis*

Genetic engineering for cell based

therapies

 

France

 

1,242

 

0.2

Total Equity Investments

454,656

98.7

Net Liquid Assets†

5,876

1.3

Total Assets†

460,532

100.0

Borrowings

(50,608) 

(11.0)

Shareholders' funds

409,924

89.0

U Denotes unlisted holding (private company).

* Includes ADR.

For a definition of terms see Glossary of Terms and Alternative Performance Measures at the end of this Announcement.

 

 

Income Statement (unaudited)

 

 

For the six months ended

31 March 2022

For the six months ended

31 March 2021

For the year ended

30 September 2021

(audited)

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

(Losses)/gains on investments

-

(142,663)

(142,663)

-

37,726

37,726

-

106,241

106,241

Currency (losses)/gains

(1)

703

702

1

2,320

2,321

(61)

1,981

1,920

Income

980

-

980

921

-

921

3,256

-

3,256

Investment management fee (note 3)

(255)

(1,019)

(1,274)

(272)

(1,089)

(1,361)

(574)

(2,298)

(2,872)

Other administrative expenses

(294)

-

(294)

(284)

-

(284)

(636)

-

(636)

Net return before finance costs and taxation

430

(142,979)

(142,549)

366

38,957

39,323

1,985

105,924

107,909

Finance costs (note 4)

(107)

(320)

(427)

(44)

(159)

(203)

(134)

(427)

(561)

Net return on ordinary activities before taxation

323

(143,299)

(142,976)

322

38,798

39,120

1,851

105,497

107,348

Tax on ordinary activities

(117)

-

(117)

(59)

-

(59)

(318)

(380)

(698)

Net return on ordinary activities after taxation

206

(143,299)

(143,093)

263

38,798

39,061

1,533

105,117

106,650

Net return per ordinary share (note 5)

0.06p

(39.50p)

(39.44p)

0.07p

10.69p

10.76p

0.42p

28.90p

29.32p

Note:

Dividends paid and payable per share (note 6)

 

Nil

 

 

 

Nil

 

0.35p

 

The total column of this statement is the profit and loss account of the Company. The supplementary revenue and capital columns are prepared under guidance published by the Association of Investment Companies.

All revenue and capital items in the above statement derive from continuing operations.

A Statement of Comprehensive Income is not required as all gains and losses of the Company have been reflected in the above statement.

 

 

Balance Sheet (unaudited)

 

At 31 March

2022

£'000

At 30 September

2021

(audited)

£'000

Fixed assets

Investments held at fair value through profit or loss (note 7)

 

454,656

 

600,351

Current assets

Debtors

Cash and cash equivalents

 

1,567

5,228

 

2,320

12,252

6,795

14,572

Creditors

Amounts falling due within one year

 

(919)

 

(1,913)

Net current assets

5,876

12,659

Total assets less current liabilities

460,532

613,010

Creditors

Amounts falling due after more than one year (note 8)

 

(50,608)

 

(51,471)

409,924

561,539

 

Capital and reserves

Share capital

Share premium account

Capital redemption reserve

Capital reserve

Revenue reserve

 

 

10,061

125,050

8,750

260,639

5,424

 

 

10,061

125,050

8,750

411,184

6,494

Shareholders' funds

409,924

561,539

Net asset value per ordinary share (borrowings at book value)*

114.2p

154.0p

Net asset value per ordinary share (borrowings at fair value)*

116.0p

154.5p

Ordinary shares in issue (note 9)

358,924,046

364,599,330

 

*See Glossary of Terms and Alternative Performance Measures at the end of this announcement.

 

Statement of Changes in Equity (unaudited)

 

 

For the six months ended 31 March 2022

Share capital

£'000

Share premium account

£'000

Capital redemption

reserve

£'000

Capital *

reserve

£'000

Revenue reserve

£'000

Shareholders'

funds

£'000

Shareholders' funds at 1 October 2021

10,061

125,050

8,750

411,184

6,494

561,539

Net return on ordinary activities after taxation

-

-

-

(143,299)

206

(143,093)

Dividends paid (note 6)

-

-

-

-

(1,276)

(1,276)

Shares bought back into treasury

-

-

-

(7,246)

-

(7,246)

 

Shareholders' funds at 31 March 2022

 

10,061

 

125,050

 

8,750

 

260,639

 

5,424

 

409,924

 

 

For the six months ended 31 March 2021

 

Share

Share premium

Capital redemption

 

Capital *

 

Revenue

 

Shareholders'

capital

account

reserve

reserve

reserve

funds

£'000

£'000

£'000

£'000

£'000

£'000

Shareholders' funds at 1 October 2020

10,061

123,749

8,750

303,860

6,228

452,648

Net return on ordinary activities after taxation

-

-

-

38,798

263

39,061

Dividends paid (note 6)

-

-

-

-

(1,268)

(1,268)

Shares issued from treasury

-

1,301

-

2,207

-

3,508

Shareholders' funds at 31 March 2021

10,061

125,050

8,750

344,865

5,223

493,949

 

* The Capital reserve as at 31 March 2022 includes investment holding gains of £25,089,000 (31 March 2021 - gains of

£153,460,000).

 

 

 

Cash Flow Statement (unaudited)

 

Six months to

31 March

2022

£'000

Six months to

31 March

2021

£'000

Cash flows from operating activities

Net return on ordinary activities before taxation

(142,976)

39,120

Net losses/(gains) on investments

142,663

(37,726)

Currency gains

(702)

(2,321)

Finance costs of borrowings

427

203

Overseas withholding tax suffered

(117)

(57)

Overseas withholding tax reclaims received

468

-

Changes in debtors and creditors

(190)

(388)

Cash from operations*

(427)

(1,169)

Interest paid

(429)

(82)

Net cash outflow from operating activities

(856)

(1,251)

Cash flows from investing activities

Acquisitions of investments

(87,304)

(64,331)

Disposals of investments

89,821

42,936

Net cash inflow/(outflow) from investing activities

2,517

(21,395)

Equity dividends paid

(1,276)

(1,268)

Cash flows from financing activities

Shares issued

-

3,508

Shares bought back

(7,246)

-

Net borrowings drawn down

-

27,263

Net cash (outflow)/inflow from financing activities

(7,246)

30,771

(Decrease)/increase in cash and cash equivalents

(6,861)

6,857

Exchange movements

(163)

548

Cash and cash equivalents at start of period

12,252

(16,882)

Cash and cash equivalents at end of period

5,228

(9,477)

* Cash from operations includes dividends received in the period of £941,000 (31 March 2021 - £827,000) and deposit interest received of £2,000

 (31 March 2021 - £2,000).

Cash and cash equivalents represent cash at bank and short-term money market deposits repayable on demand.

 

 

Notes to the condensed financial statements (unaudited)

 

 

1 The condensed Financial Statements for the six months to 31 March 2022 comprise the statements set out above together with the related notes 1 to 11 below. They have been prepared in accordance with FRS 104 'Interim Financial Reporting' and the AIC's Statement of Recommended Practice issued in November 2014 and updated in October 2020 and April 2021 with consequential amendments and have not been audited or reviewed by the Auditor pursuant to the Auditing Practices Board Guidance 'Review of Interim Financial Information'. The Financial Statements for the six months to 31 March 2022 have been prepared on the basis of the same accounting policies as set out in the Company's Annual Report and Financial Statements at 30 September 2021.

Going Concern

The Directors have considered the nature of the Company's principal risks and uncertainties, as set below, as well as the ongoing impact of market volatility during the Covid-19 pandemic and hostilities in Ukraine. In addition, the Company's investment objective and policy, assets and liabilities and projected income and expenditure, together with the dividend policy have been taken into consideration and it is the Directors' opinion that the Company has adequate resources to continue in operational existence for the foreseeable future. The Company's assets, the majority of which are investments in quoted securities which are readily realisable, exceed its liabilities significantly.

All borrowings require the prior approval of the Board and gearing levels are reviewed by the Board on a regular basis. The Directors consider it appropriate to adopt the going concern basis of accounting in preparing these Financial Statements and confirm that they are not aware of any material uncertainties which may affect the Company's ability to continue to do so over a period of at least twelve months from the date of approval of these Financial Statements.

2 The financial information contained within this Interim Financial Report does not constitute statutory accounts as defined in sections 434 to 436 of the Companies Act 2006. The financial information for the year ended 30 September 2021 has been extracted from the statutory accounts which have been filed with the Registrar of Companies. The Auditor's Report on those accounts was not qualified, did not include a reference to any matters to which the Auditor drew attention by way of emphasis without qualifying their report, and did not contain a statement under sections 498(2) or (3) of the Companies Act 2006.

3 Baillie Gifford & Co Limited, a wholly owned subsidiary of Baillie Gifford & Co, was appointed by the Company as its Alternative Investment Fund Manager (AIFM) and Company Secretary on 29 November 2019. The investment management function has been delegated to Baillie Gifford & Co. The management agreement can be terminated on three months' notice. The annual management fee is 0.55% of the lower of (i) the Company's market capitalisation and (ii) the Company's net asset value (which shall include income), in either case up to £500 million, and 0.50% of the amount of the lower of the Company's market capitalisation or net asset value above £500 million, calculated and payable quarterly.

4 Finance Costs

 

Six months to 31 March 2022 Revenue Capital

£'000 £'000

Total

£'000

Loan interest

Loan arrangement fee

Negative interest on cash balances

79

1

27

318

2

-

397

3

27

107

320

427

Year to 30 September 2021 (audited)

Revenue

£'000

Capital

£'000

Total

£'000

Overdraft facility

19

76

95

Loan interest

87

349

436

Loan arrangement fee

1

2

3

Negative interest on cash balances

27

-

27

134

427

561

 

 

Six months to 31 March 2021

Revenue

£'000

Capital

£'000

Total

£'000

Overdraft facility

15

59

74

Loan interest

24

98

122

Loan arrangement fee

1

2

3

Negative interest on cash balances

4

-

4

44

159

203

 

5.

 

 

 

 

 

 

Six months to 31 March

2022

£'000

 

Six months to 31 March

2021

£'000

Year to 30 September

2021

(audited)

£'000

 

Net return per ordinary share

Revenue return on ordinary activities after taxation Capital return on ordinary activities after taxation

 

206

(143,299)

 

263

38,798

 

1,533

105,117

 

Total net return

(143,093)

39,061

106,650

 

Weighted average number of ordinary shares in issue

 

362,745,292

 

362,827,352

 

363,715,768

 

 

 

Net return per ordinary share is based on the above totals of revenue and capital and the weighted average number of ordinary shares in issue during each period.

There are no dilutive or potentially dilutive shares in issue.

6.

Six months to 31 March

2022

£'000

Six months to 31 March

2021

£'000

 

Dividends

Amounts recognised as distributions in the period:

Final dividend 0.35p (2021 - 0.35p), paid 11 February 2022

 

 

1,276

 

 

1,268

1,276

1,268

Dividends proposed in the period:

Interim dividend - nil (2021 - nil)

 

-

 

-

-

-

 

 

7 Fair Value Hierarchy

The Company's investments are financial assets held at fair value through profit or loss. The fair value hierarchy used to analyse the basis on which the fair values of financial instruments held at fair value through the profit or loss account are measured is described below. Fair value measurements are categorised on the basis of the lowest level input that is significant to the fair value measurement.

Level 1 - using unadjusted quoted prices for identical instruments in an active market;

Level 2 - using inputs, other than quoted prices included within Level 1, that are directly or indirectly observable (based on market data); and

Level 3 - using inputs that are unobservable (for which market data is unavailable).

An analysis of the Company's financial assets based on the fair value hierarchy described above is shown below.

 

 

As at 31 March 2022

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

Listed equities

418,416

-

-

418,416

Unlisted securities

-

-

36,240

36,240

Total financial asset investments

418,416

-

36,240

454,656

 

Level 1

Level 2

Level 3

Total

As at 30 September 2021

£'000

£'000

£'000

£'000

Listed securities

572,399

-

-

572,399

Unlisted securities

-

-

27,952

27,952

Total financial asset investments

572,399

-

27,952

600,351

 

Unlisted investments are valued at fair value by the Directors following a detailed review and appropriate challenge of the valuations proposed by the Managers. The Managers' unlisted valuation policy applies methodologies consistent with the International Private Equity and Venture Capital Valuation Guidelines ('IPEV'). These methodologies can be categorised as follows: (a) market approach (multiples, industry valuation benchmarks and available market prices); (b) income approach (discounted cash flows); and (c) replacement cost approach (net assets). The Company's holdings in unlisted investments are categorised as Level 3 as unobservable data is a significant input to their fair value measurements.

 

8 The Company has a €30 million overdraft credit facility with The Northern Trust Company for the purpose of pursuing its investment objective. At 31 March 2022, nil had been drawn down under the facility (31 March 2021 - €11.2 million (£9.6 million), 30 September 2021 - nil). Interest is charged at 1.25% above the European Central Bank Main Refinancing Rate. On 8 December 2020 the Company issued €30 million of long-term, fixed rate, senior, unsecured privately placed notes ('loan notes'), with a fixed coupon of 1.57% to be repaid on 8 December 2040 and on 24 June 2021 issued a further €30 million of loan notes with a fixed coupon of 1.55% to be repaid on 24 June 2036. At 31 March 2022 the book value of the loan notes amounted to £50,608,000 (31 March 2021 - £25,487,000, 30 September 2021 - £51,471,000). The fair value of the loan notes at 31 March 2022 was £44,238,000 (31 March 2021 -£25,391,000, 30 September 2021 - £49,855,000).

 

9 The Company has authority to allot shares under section 551 of the Companies Act 2006. The Board has authorised use of this authority to

issue new shares at a premium to net asset value in order to enhance the net asset value per share for existing shareholders and improve the

liquidity of the Company's shares. In the six months to 31 March 2022 no ordinary shares were issued (in the year to 30 September 2021 the

Company issued a total of 2,400,000 shares on a non pre-emptive basis (nominal value £60,000, representing 0.7% of the issued share capital

at 30 September 2020) at a premium to net asset value (on the basis of debt valued at book value) raising net proceeds of £3,508,000).

 

The Company also has authority to buy back shares. In the six months to 31 March 2022 5,675,284 ordinary shares were bought back into treasury at a cost of £7,246,000 (in the year to 30 September 2021 no ordinary shares were bought back for cancellation or into treasury).

 

10 During the period, transaction costs on equity purchases amounted to £64,000 (31 March 2021 - £77,000; 30 September 2021 - £96,000)

and on equity sales £36,000 (31 March 2021 - £25,000; 30 September 2021 - £45,000).

 

11 Related Party Transactions

There have been no transactions with related parties during the first six months of the current financial year that have materially affected the financial position or the performance of the Company during that period and there have been no changes in the related party transactions described in the last Annual Report and Financial Statements that could have had such an effect on the Company during that period.

None of the views expressed in this document should be construed as advice to buy or sell a particular investment.

 

 

Principal Risks and Uncertainties

 

The principal risks facing the Company are financial risk, investment strategy risk, discount risk, regulatory risk, custody and depositary risk, operational risk, leverage risk and political risk. An explanation of these risks and how they are managed is set out on pages 7 and 8 of the Company's Annual Report and Financial Statements for the year to 30 September 2021 which is available on the Company's website: bgeuropeangrowth.com. The principal risks and uncertainties have not changed since the date of the Annual Report.

 

Responsibility Statement

 

We confirm that to the best of our knowledge:

a)  the condensed set of Financial Statements has been prepared in accordance with FRS 104 'Interim Financial Reporting';

b)  the Interim Management Report includes a fair review of the information required by Disclosure Guidance and Transparency Rule 4.2.7R (indication of important events during the first six months, their impact on the Financial Statements and a description of the principal risks and uncertainties for the remaining six months of the year); and

c)  the Interim Financial Report includes a fair review of the information required by Disclosure Guidance and Transparency Rule 4.2.8R (disclosure of related party transactions and changes therein).

 

By order of the Board

Michael MacPhee

Chairman

16 May 2022

 

Glossary of Terms and Alternative Performance Measures (APM)

 

Total Assets

Total assets less current liabilities, before deduction of all borrowings.

Shareholders' Funds

Shareholders' Funds is the value of all assets held less all liabilities, with borrowings deducted at book cost.

Net Asset Value

Net Asset Value (NAV) is the value of total assets less liabilities (including borrowings). The NAV per share is calculated by dividing this amount by the number of ordinary shares in issue (excluding treasury shares).

Net Asset Value (Borrowings at Book Value)

Borrowings are valued at nominal book value (book cost).

Net Asset Value (Borrowings at Fair Value) (APM)

Borrowings are valued at an estimate of their market worth.

Net Liquid Assets

Net liquid assets comprise current assets less current liabilities, excluding borrowings.

Discount/Premium (APM)

As stockmarkets and share prices vary, an investment trust's share price is rarely the same as its NAV per share. When the share price is lower than the NAV per share it is said to be trading at a discount. The size of the discount is calculated by subtracting the share price from the NAV per share and is usually expressed as a percentage of the NAV per share. If the share price is higher than the NAV per share, it is said to be trading at a premium.

Total Return (APM)

The total return is the return to shareholders after reinvesting the net dividend on the date that the share price goes ex-dividend.

Net Asset Value (Reconciliation of NAV at Book Value to NAV at Fair Value)

 

31 March

2022

Net Asset Value per ordinary share (borrowings at book value)

 

114.2p

Shareholders' funds (borrowings at book value)

Add: book value of borrowings Less: fair value of borrowings

£409,924,000

£50,608,000

£44,238,000

Shareholders' funds (borrowings at fair value)

 

£416,294,000

Number of shares in issue

358,924,046

Net Asset Value per ordinary share (borrowings at fair value)

 

116.0p

Gearing (APM)

At its simplest, gearing is borrowing. Just like any other public company, an investment trust can borrow money to invest in additional investments for its portfolio. The effect of the borrowing on the shareholders' assets is called 'gearing'. If the Company's assets grow, the shareholders' assets grow proportionately more because the debt remains the same. But if the value of the Company's assets falls, the situation is reversed. Gearing can therefore enhance performance in rising markets but can adversely impact performance in falling markets.

 

Potential gearing is the Company's borrowings expressed as a percentage of shareholders' funds.

Gearing represents borrowings less cash and cash equivalents expressed as a percentage of shareholders' funds.

Active Share (APM)

Active share, a measure of how actively a portfolio is managed, is the percentage of the portfolio that differs from its comparative index. It is calculated by deducting from 100 the percentage of the portfolio that overlaps with the comparative index. An active share of 100 indicates no overlap with the index and an active share of zero indicates a portfolio that tracks the index.

 

 

Third Party Data Provider Disclaimer

No third party data provider ('Provider') makes any warranty, express or implied, as to the accuracy, completeness or timeliness of the data contained herewith nor as to the results to be obtained by recipients of the data. No Provider shall in any way be liable to any recipient of the data for any inaccuracies, errors or omissions in the index data included in this document, regardless of cause, or for any damages (whether direct or indirect) resulting therefrom.

No Provider has any obligation to update, modify or amend the data or to otherwise notify a recipient thereof in the event that any matter stated herein changes or subsequently becomes inaccurate.

Without limiting the foregoing, no Provider shall have any liability whatsoever to you, whether in contract (including under an indemnity), in tort (including negligence), under a warranty, under statute or otherwise, in respect of any loss or damage suffered by you as a result of or in connection with any opinions, recommendations, forecasts, judgements, or any other conclusions, or any course of action determined, by you or any third party, whether or not based on the content, information or materials contained herein.

 

FTSE Index Data

London Stock Exchange Group plc and its group undertakings (collectively, the 'LSE Group'). © LSE Group 2022. FTSE Russell is a trading name of certain of the LSE Group companies. 'FTSE®' 'Russell®', FTSE Russell ®, is/are a trade mark(s) of the relevant LSE Group companies and is/are used by any other LSE Group company under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication.

No further distribution of data from the LSE Group is permitted without the relevant LSE Group company's express written consent. The LSE Group does not promote, sponsor or endorse the content of this communication.

 

 

Sustainable Finance Disclosure Regulation ('SFDR')

 

The EU SFDR does not have a direct impact in the UK due to Brexit, however, it applies to third-country products marketed in the EU. As Baillie Gifford European Growth Trust is marketed in the EU by the AIFM, Baillie Gifford & Co Limited, via the National Private Placement Regime (NPPR) the following disclosures have been provided to comply with the high-level requirements of SFDR.

The AIFM has adopted Baillie Gifford & Co's Governance and Sustainable Principles and Guidelines as its policy on integration of sustainability risks in investment decisions. Baillie Gifford & Co's approach to investment is based on identifying and holding high quality growth businesses that enjoy sustainable competitive advantages in their marketplace. To do this it looks beyond current financial performance, undertaking proprietary research to build up an in-depth knowledge of an individual company and a view on its long-term prospects. This includes the consideration of sustainability factors (environmental, social and/ or governance matters) which it believes will positively or negatively influence the financial returns of an investment.

More detail on the Investment Manager's approach to sustainability can be found in the Governance and Sustainability Principles and Guidelines document, available publicly on the Baillie Gifford website (bailliegifford.com/en/uk/about-us/

literature-library/corporate-governance/ governance-sustainability-principles-and-guidelines/).

 

Taxonomy Regulation

The Taxonomy Regulation establishes an EU-wide framework or criteria for environmentally sustainable economic activities in respect of six environmental objectives. It builds on the disclosure requirements under SFDR by introducing additional disclosure obligations in respect of AIFs that invest in an economic activity that contributes to an environmental objective.

The Company does not commit to make sustainable investments as defined under SFDR. As such, the underlying investments do not take into account the EU criteria for environmentally sustainable economic activities.

 

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR GPUPPAUPPGQQ
Date   Source Headline
10th May 20245:11 pmRNSTransaction in Own Shares
10th May 202411:39 amRNSNet Asset Value(s)
9th May 202411:36 amRNSNet Asset Value(s)
8th May 202411:37 amRNSNet Asset Value(s)
7th May 202412:18 pmRNSNet Asset Value(s)
7th May 202411:36 amRNSNet Asset Value(s)
3rd May 202411:53 amRNSNet Asset Value(s)
2nd May 202411:22 amRNSNet Asset Value(s)
1st May 20243:28 pmRNSNet Asset Value(s)
1st May 202410:45 amRNSTotal Voting Rights
30th Apr 20245:13 pmRNSTransaction in Own Shares
30th Apr 202412:01 pmRNSNet Asset Value(s)
29th Apr 202412:12 pmRNSNet Asset Value(s)
26th Apr 20244:51 pmRNSTransaction in Own Shares
26th Apr 202411:54 amRNSNet Asset Value(s)
25th Apr 202411:34 amRNSNet Asset Value(s)
24th Apr 202412:40 pmRNSNet Asset Value(s)
23rd Apr 20244:45 pmRNSTransaction in Own Shares
23rd Apr 202411:56 amRNSNet Asset Value(s)
22nd Apr 202412:20 pmRNSNet Asset Value(s)
19th Apr 20243:41 pmRNSDirector/PDMR Shareholding
19th Apr 20241:24 pmRNSNet Asset Value(s)
18th Apr 202411:26 amRNSNet Asset Value(s)
17th Apr 20244:59 pmRNSTransaction in Own Shares
17th Apr 202412:10 pmRNSNet Asset Value(s)
16th Apr 20244:05 pmRNSNet Asset Value(s)
15th Apr 202412:07 pmRNSNet Asset Value(s)
12th Apr 20244:57 pmRNSTransaction in Own Shares
12th Apr 202411:37 amRNSNet Asset Value(s)
11th Apr 20245:13 pmRNSTransaction in Own Shares
11th Apr 202411:12 amRNSNet Asset Value(s)
10th Apr 202412:06 pmRNSNet Asset Value(s)
9th Apr 20245:12 pmRNSTransaction in Own Shares
9th Apr 202411:23 amRNSNet Asset Value(s)
8th Apr 202411:06 amRNSNet Asset Value(s)
5th Apr 202411:47 amRNSNet Asset Value(s)
4th Apr 202411:21 amRNSNet Asset Value(s)
3rd Apr 20245:25 pmRNSTransaction in Own Shares
3rd Apr 202411:17 amRNSNet Asset Value(s)
2nd Apr 20245:14 pmRNSClosed Period Confirmation
2nd Apr 20244:31 pmRNSNet Asset Value(s)
2nd Apr 20243:58 pmRNSNet Asset Value(s)
2nd Apr 20242:54 pmRNSTotal Voting Rights
2nd Apr 20241:41 pmRNSNet Asset Value(s)
28th Mar 20244:53 pmRNSTransaction in Own Shares
28th Mar 202411:45 amRNSNet Asset Value(s)
27th Mar 202411:53 amRNSNet Asset Value(s)
26th Mar 20244:56 pmRNSTransaction in Own Shares
26th Mar 202411:38 amRNSNet Asset Value(s)
25th Mar 202412:20 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.